request Request a Protocol
ask Ask a question
Favorite

For the scratch migration assay, cells (2×104 cells/well/100 µl) were seeded into 96-well plates, allowed to adhere overnight and treated with 25 µg/ml mitomycin (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for 30 min. Following the creation of wounds on the confluent monolayers using a 96-pin Wound Maker (IncuCyte; Essen Bioscience, Ann Arbor, MI, USA), the plates were placed into the IncuCyte chamber (Essen Bioscience) and incubated with or without RA in a 5% CO2 incubator at 37°C. The wound images were captured every 3 h using an IncuCyte Zoom system (Essen Bioscience). The wound closure proportion at each time point was calculated based on the wound width at 0 h as 100%. For the Transwell migration assay, a Transwell chamber (10 mm diameter, 8 µm pore size polycarbonate membrane; Corning Incorporated) was used. In the lower chamber, 600 µl 10% FBS in DMEM or EGM-2 was used for tumor cells or HUVECs, respectively. In the upper chamber, cells (1×105 cells/well) suspended in 100 µl serum-free DMEM or endothelial cell basal medium-2 (EBM-2) were added. Following incubation at 37°C with 5% CO2 for 12 h, the migrated cells were fixed, stained with 0.2% crystal violet/20% (w/v) methanol solution, and counted using a phase-contrast microscope (magnification, ×100).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A